Cargando…
DoE-Assisted Development of a Novel Glycosaminoglycan-Based Injectable Formulation for Viscosupplementation
The aim of the present work was the development of a novel glycosaminoglycan (GAG)-based injectable formulation intended for intra-articular administration that should best mimic the healthy synovial fluid. Hyaluronic acid (HA) was chosen among GAG polymers, since it is the most abundant component o...
Autores principales: | Cicognani, Marta, Rossi, Silvia, Vecchi, Gabriele, Giori, Andrea Maria, Ferrari, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407620/ https://www.ncbi.nlm.nih.gov/pubmed/32698313 http://dx.doi.org/10.3390/pharmaceutics12070681 |
Ejemplares similares
-
Viscosupplementation in the hip: evaluation of hyaluronic acid formulations
por: van den Bekerom, M. P. J., et al.
Publicado: (2007) -
VISCOSUPPLEMENTATION
por: de Rezende, Márcia Uchôa, et al.
Publicado: (2015) -
Viscosupplementation in the treatment of osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2012) -
Viscosupplementation During Rehabilitation
por: Silvers, Holly J.
Publicado: (2014) -
Characterization of viscosupplementation formulations using chemical exchange saturation transfer (ViscoCEST)
por: Haris, Mohammad, et al.
Publicado: (2016)